PHARMACISTS' REPORT
 
Novel Migraine Drug Now Available for Prescription
Eli Lilly’s lasmiditan (Reyvow) C-V 50 mg and 100 mg for the acute treatment of migraine is now available for prescription.
Read more
 
FDA Requests Withdrawal of Bacitracin Injection from Market
Officials with the FDA are calling for manufacturers of bacitracin for injection to voluntarily withdraw their product from the market, according to a drug safety communication.
Read more
 
Read More
 
New Phase 3 Data on Baricitinib Efficacy in Atopic Dermatitis
North Carolina Pharmacy Team Celebrated for Triumph Over Hurricane Florence
Eli Lilly Will Donate Additional Insulin Vials to US Free Clinics
Policy Eliminating Non-Medical Vaccine Exemptions Linked to Improved Coverage Rates